Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

Mass Spectrometry-based Absolute Quantification of 20S Proteasome Status for Controlled Ex-vivo Expansion of Human Adipose-derived Mesenchymal Stromal/Stem Cells.

Menneteau T, Fabre B, Garrigues L, Stella A, Zivkovic D, Roux-Dalvai F, Mouton-Barbosa E, Beau M, Renoud ML, Amalric F, Sensébé L, Gonzalez-de-Peredo A, Ader I, Burlet-Schiltz O, Bousquet MP.

Mol Cell Proteomics. 2019 Apr;18(4):744-759. doi: 10.1074/mcp.RA118.000958. Epub 2019 Jan 30.

2.

Deciphering preferential interactions within supramolecular protein complexes: the proteasome case.

Fabre B, Lambour T, Garrigues L, Amalric F, Vigneron N, Menneteau T, Stella A, Monsarrat B, Van den Eynde B, Burlet-Schiltz O, Bousquet-Dubouch MP.

Mol Syst Biol. 2015 Jan 5;11(1):771. doi: 10.15252/msb.20145497.

3.

Label-free quantitative proteomics reveals the dynamics of proteasome complexes composition and stoichiometry in a wide range of human cell lines.

Fabre B, Lambour T, Garrigues L, Ducoux-Petit M, Amalric F, Monsarrat B, Burlet-Schiltz O, Bousquet-Dubouch MP.

J Proteome Res. 2014 Jun 6;13(6):3027-37. doi: 10.1021/pr500193k. Epub 2014 May 23. Erratum in: J Proteome Res. 2014 Dec 5;13(12):6197-8.

PMID:
24804812
4.

Subcellular distribution and dynamics of active proteasome complexes unraveled by a workflow combining in vivo complex cross-linking and quantitative proteomics.

Fabre B, Lambour T, Delobel J, Amalric F, Monsarrat B, Burlet-Schiltz O, Bousquet-Dubouch MP.

Mol Cell Proteomics. 2013 Mar;12(3):687-99. doi: 10.1074/mcp.M112.023317. Epub 2012 Dec 13.

5.

[Translational research and Cancer Plan].

Vassal G, Borella L, Pierre A, Pamphile R, Bourrie B, Meflah K, Amalric F, Pauporte I, Caillot JL, Formstecher P, Demers B, Dumontet C, Grégoire M, Lethiec F, Boue AM, Tonelli D, Pilsudski R, Van Hijfte L, Cailliot C, Vrignaud P, Merlin JL, Oudet P, Arnoux PY, Lassale C.

Bull Cancer. 2007 Dec;94(12):1107-11. French.

6.

Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node.

Carrière V, Colisson R, Jiguet-Jiglaire C, Bellard E, Bouche G, Al Saati T, Amalric F, Girard JP, M'Rini C.

Cancer Res. 2005 Dec 15;65(24):11639-48.

7.

A comparative study of endothelial cell markers expressed in chronically inflamed human tissues: MECA-79, Duffy antigen receptor for chemokines, von Willebrand factor, CD31, CD34, CD105 and CD146.

Middleton J, Americh L, Gayon R, Julien D, Mansat M, Mansat P, Anract P, Cantagrel A, Cattan P, Reimund JM, Aguilar L, Amalric F, Girard JP.

J Pathol. 2005 Jul;206(3):260-8.

PMID:
15887283
8.

Exogenously added fibroblast growth factor 2 (FGF-2) to NIH3T3 cells interacts with nuclear ribosomal S6 kinase 2 (RSK2) in a cell cycle-dependent manner.

Soulet F, Bailly K, Roga S, Lavigne AC, Amalric F, Bouche G.

J Biol Chem. 2005 Jul 8;280(27):25604-10. Epub 2005 May 6.

9.

The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity.

Clouaire T, Roussigne M, Ecochard V, Mathe C, Amalric F, Girard JP.

Proc Natl Acad Sci U S A. 2005 May 10;102(19):6907-12. Epub 2005 Apr 29.

10.

Modulation of cellular response to cisplatin by a novel inhibitor of DNA polymerase beta.

Boudsocq F, Benaim P, Canitrot Y, Knibiehler M, Ausseil F, Capp JP, Bieth A, Long C, David B, Shevelev I, Frierich-Heinecken E, Hübscher U, Amalric F, Massiot G, Hoffmann JS, Cazaux C.

Mol Pharmacol. 2005 May;67(5):1485-92. Epub 2005 Feb 9.

PMID:
15703384
11.

Endothelial cell phenotypes in the rheumatoid synovium: activated, angiogenic, apoptotic and leaky.

Middleton J, Americh L, Gayon R, Julien D, Aguilar L, Amalric F, Girard JP.

Arthritis Res Ther. 2004;6(2):60-72. Epub 2004 Mar 8. Review.

12.

Plasticity of endothelial cells: rapid dedifferentiation of freshly isolated high endothelial venule endothelial cells outside the lymphoid tissue microenvironment.

Lacorre DA, Baekkevold ES, Garrido I, Brandtzaeg P, Haraldsen G, Amalric F, Girard JP.

Blood. 2004 Jun 1;103(11):4164-72. Epub 2004 Feb 19.

PMID:
14976058
13.

Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Baekkevold ES, Roussigné M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M, Haraldsen G, Girard JP.

Am J Pathol. 2003 Jul;163(1):69-79.

14.

THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.

Roussigne M, Cayrol C, Clouaire T, Amalric F, Girard JP.

Oncogene. 2003 Apr 24;22(16):2432-42.

PMID:
12717420
15.

Nucleolin provides a link between RNA polymerase I transcription and pre-ribosome assembly.

Roger B, Moisand A, Amalric F, Bouvet P.

Chromosoma. 2003 Mar;111(6):399-407. Epub 2003 Feb 11.

PMID:
12644954
16.

Molecular and functional characterization of SLC26A11, a sodium-independent sulfate transporter from high endothelial venules.

Vincourt JB, Jullien D, Amalric F, Girard JP.

FASEB J. 2003 May;17(8):890-2. Epub 2003 Mar 5.

PMID:
12626430
17.

The THAP domain: a novel protein motif with similarity to the DNA-binding domain of P element transposase.

Roussigne M, Kossida S, Lavigne AC, Clouaire T, Ecochard V, Glories A, Amalric F, Girard JP.

Trends Biochem Sci. 2003 Feb;28(2):66-9.

PMID:
12575992
18.

Molecular cloning of SLC26A7, a novel member of the SLC26 sulfate/anion transporter family, from high endothelial venules and kidney.

Vincourt JB, Jullien D, Kossida S, Amalric F, Girard JP.

Genomics. 2002 Feb;79(2):249-56.

PMID:
11829495
19.

rDNA transcription during Xenopus laevis oogenesis.

Roger B, Moisand A, Amalric F, Bouvet P.

Biochem Biophys Res Commun. 2002 Feb 1;290(4):1151-60.

PMID:
11811983
20.

Repression of RNA polymerase I transcription by nucleolin is independent of the RNA sequence that is transcribed.

Roger B, Moisand A, Amalric F, Bouvet P.

J Biol Chem. 2002 Mar 22;277(12):10209-19. Epub 2001 Dec 31.

21.

Fibroblast growth factor-2 interacts with free ribosomal protein S19.

Soulet F, Al Saati T, Roga S, Amalric F, Bouche G.

Biochem Biophys Res Commun. 2001 Nov 30;289(2):591-6.

PMID:
11716516
22.

Revealing the unseen: the organizer region of the nucleolus.

Biggiogera M, Malatesta M, Abolhassani-Dadras S, Amalric F, Rothblum LI, Fakan S.

J Cell Sci. 2001 Sep;114(Pt 17):3199-205.

23.

Two different combinations of RNA-binding domains determine the RNA binding specificity of nucleolin.

Ginisty H, Amalric F, Bouvet P.

J Biol Chem. 2001 Apr 27;276(17):14338-43. Epub 2001 Jan 18.

24.

Nucleoli undergo structural and molecular modifications during hibernation.

Malatesta M, Gazzanelli G, Battistelli S, Martin TE, Amalric F, Fakan S.

Chromosoma. 2000 Nov;109(7):506-13.

PMID:
11151681
25.

Interaction of nucleolin with an evolutionarily conserved pre-ribosomal RNA sequence is required for the assembly of the primary processing complex.

Ginisty H, Serin G, Ghisolfi-Nieto L, Roger B, Libante V, Amalric F, Bouvet P.

J Biol Chem. 2000 Jun 23;275(25):18845-50.

26.

Ultrastructural analysis of nucleolar transcription in cells microinjected with 5-bromo-UTP.

Cmarko D, Verschure PJ, Rothblum LI, Hernandez-Verdun D, Amalric F, van Driel R, Fakan S.

Histochem Cell Biol. 2000 Mar;113(3):181-7.

PMID:
10817672
27.

Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells.

Besset S, Vincourt JB, Amalric F, Girard JP.

FASEB J. 2000 Feb;14(2):345-54.

PMID:
10657990
28.

Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor.

Bailly K, Soulet F, Leroy D, Amalric F, Bouche G.

FASEB J. 2000 Feb;14(2):333-44.

PMID:
10657989
29.

Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization.

Girard JP, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzaeg P, Amalric F.

Am J Pathol. 1999 Dec;155(6):2043-55.

30.

Molecular cloning and functional analysis of SUT-1, a sulfate transporter from human high endothelial venules.

Girard JP, Baekkevold ES, Feliu J, Brandtzaeg P, Amalric F.

Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12772-7.

31.

FGF-2 dimerization involvement in growth factor mediated cell proliferation but not cell differentiation.

Van den Berghe L, Mortier I, Zanibellato C, Amalric F, Prats H, Bugler B.

Biochem Biophys Res Commun. 1998 Nov 18;252(2):420-7.

PMID:
9826545
32.

[Results of the conservative surgical and irradiation treatment of 132 nonpalpable ductal carcinomas in situ of the breast].

Amalric R, Brandone H, Dubau A, Hans D, Brandone JM, Robert F, Pollet JF, Amalric F, Rouah Y, Thomassin L, Giraud D, Henric A, Martin PM, Romain S.

Cancer Radiother. 1998 Jan-Feb;2(1):19-26. Review. French.

PMID:
9749092
33.

Nucleolin interacts with several ribosomal proteins through its RGG domain.

Bouvet P, Diaz JJ, Kindbeiter K, Madjar JJ, Amalric F.

J Biol Chem. 1998 Jul 24;273(30):19025-9.

34.

An Arg/Lys-rich core peptide mimics TRBP binding to the HIV-1 TAR RNA upper-stem/loop.

Erard M, Barker DG, Amalric F, Jeang KT, Gatignol A.

J Mol Biol. 1998 Jun 26;279(5):1085-99.

PMID:
9642086
35.

Sulfation in high endothelial venules: cloning and expression of the human PAPS synthetase.

Girard JP, Baekkevold ES, Amalric F.

FASEB J. 1998 May;12(7):603-12.

PMID:
9576487
36.

Nucleolin functions in the first step of ribosomal RNA processing.

Ginisty H, Amalric F, Bouvet P.

EMBO J. 1998 Mar 2;17(5):1476-86.

37.

Biosynthesis of sulfated L-selectin ligands in human high endothelial venules (HEV).

Girard JP, Amalric F.

Adv Exp Med Biol. 1998;435:55-62. Review.

PMID:
9498065
38.

RNA recognition by the joint action of two nucleolin RNA-binding domains: genetic analysis and structural modeling.

Bouvet P, Jain C, Belasco JG, Amalric F, Erard M.

EMBO J. 1997 Sep 1;16(17):5235-46.

39.

Two RNA-binding domains determine the RNA-binding specificity of nucleolin.

Serin G, Joseph G, Ghisolfi L, Bauzan M, Erard M, Amalric F, Bouvet P.

J Biol Chem. 1997 May 16;272(20):13109-16.

40.

Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells.

Vagner S, Touriol C, Galy B, Audigier S, Gensac MC, Amalric F, Bayard F, Prats H, Prats AC.

J Cell Biol. 1996 Dec;135(5):1391-402.

41.

Fibroblast growth factor-2 binds to the regulatory beta subunit of CK2 and directly stimulates CK2 activity toward nucleolin.

Bonnet H, Filhol O, Truchet I, Brethenou P, Cochet C, Amalric F, Bouche G.

J Biol Chem. 1996 Oct 4;271(40):24781-7.

42.

Nucleolin is a sequence-specific RNA-binding protein: characterization of targets on pre-ribosomal RNA.

Ghisolfi-Nieto L, Joseph G, Puvion-Dutilleul F, Amalric F, Bouvet P.

J Mol Biol. 1996 Jul 5;260(1):34-53.

PMID:
8676391
43.

Localization of nucleolin binding sites on human and mouse pre-ribosomal RNA.

Serin G, Joseph G, Faucher C, Ghisolfi L, Bouche G, Amalric F, Bouvet P.

Biochimie. 1996;78(6):530-8.

PMID:
8915542
44.
45.

Human DNA helicase IV is nucleolin, an RNA helicase modulated by phosphorylation.

Tuteja N, Huang NW, Skopac D, Tuteja R, Hrvatic S, Zhang J, Pongor S, Joseph G, Faucher C, Amalric F, et al.

Gene. 1995 Jul 28;160(2):143-8.

PMID:
7642087
46.

Expression of basic fibroblast growth factor (bFGF) and FGF-receptors in human leukemic cells.

Allouche M, Bayard F, Clamens S, Fillola G, Sié P, Amalric F.

Leukemia. 1995 Jan;9(1):77-86.

PMID:
7845032
47.

Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes.

Vagner S, Gensac MC, Maret A, Bayard F, Amalric F, Prats H, Prats AC.

Mol Cell Biol. 1995 Jan;15(1):35-44.

48.
49.

[Conservative treatment of sub-clinical noninfiltrating cancers of the breast (102 EOA in situ, TONO)].

Brandone H, Ayme Y, Hans D, Dubau A, Brandone JM, Robert F, Pollet JF, Amalric F, Bressac C, Jacquemier J, et al.

Ann Chir. 1995;49(1):56-61. Review. French.

PMID:
7741470
50.

Population: malady or symptom?

Amalric F, Banuri T.

Third World Q. 1994 Dec;15(4):691-706.

PMID:
12319854

Supplemental Content

Loading ...
Support Center